# Procalcitonin Levels as a Predictor of Bacteremia in Febrile Pediatric Oncology Patients-Pilot Study

> **NCT02417168** · — · TERMINATED · sponsor: **CAMC Health System** · enrollment: 1 (actual)

## Conditions studied

- Cancer
- Bacteremia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02417168
- **Lead sponsor:** CAMC Health System
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2015-07-01
- **Primary completion:** 2016-03-01
- **Final completion:** 2016-03-01
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** PI left study site
- **Last updated:** 2020-03-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02417168

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02417168, "Procalcitonin Levels as a Predictor of Bacteremia in Febrile Pediatric Oncology Patients-Pilot Study". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02417168. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*